Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects
2024 · Drugs in R&D · 1 citations
https://doi.org/10.1007/s40268-024-00486-2
S
Shumao Ni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Shumao Ni is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat